A Look at Incyte’s Product Portfolio
Incyte has classified its oncology product portfolio into targeted anti-cancer therapies and immuno-oncology or immunotherapies.
Why These Collaborations Are Important to Incyte
Incyte’s (INCY) Jakafi is distributed in the US markets through its network of specialty pharmacy providers and wholesalers for direct delivery to patients or patients’ pharmacies.
What’s in Incyte’s Product Portfolio?
Incyte’s (INCY) product portfolio includes drugs for oncology as well as other areas.